Early Detection
424 articles
Reducing Pancreatic Cancer Disparities Through the NCI Community Oncology Research Program (NCORP)
The NCI’s Community Oncology Research Program (NCORP) aims to reduce cancer disparities among the underserved by giving everyone access to clinical trials.
New Study Tackles the Link Between Sleep Disruption and Cachexia
Cachexia occurs frequently among pancreatic cancer patients. Dr. Evan Noch is looking at how sleep disruption and cachexia interact.
Precision Promise Places Patients at Center of Research
Dr. Diane Simeone explains the different approach to pancreatic cancer clinical trials taken by the Precision Promise program.
Using Tumor Tissue Samples to Break Down Assumptions About Pancreatic Cancer
Dr. Christine Iacobuzio-Donahue uses tumor tissue samples to study how pancreatic cancer tumors develop, so she can find ways to stop the disease.
Let’s Win and Partners Present Poster and Abstract at Gastrointestinal Cancer Symposium
Let’s Win and partners presented a poster and abstract that highlights the first pancreatic cancer group Twitter chat at the January 2018 ASCO GI meeting.
Let’s Win Turns 5!
Let’s Win has reached its 5th anniversary! We have grown, with more than 500 original stories about treatments and trials to help patients.
LET’S WIN! PANCREATIC CANCER Turns 5!
Let’s Win has reached its 5th anniversary. Read about our development and what we have accomplished in 5 short years.
Understanding How Super-Enhancers Rev Up Pancreatic Cancer Growth
Researcher Ronald Evans, Ph.D., and his team at the Salk Institute are focusing on how super-enhancers stimulate pancreatic cancer growth.